View More View Less
  • 1 Pharmaceutical Chemistry Department, K.B. Institute of Pharmaceutical Education and Research, Gandhinagar, Gujarat 382023, India
Restricted access

Summary

In the present study, a design of experiment (DoE) approach was used to optimize chromatographic conditions for the development of a high-performance thin-layer chromatography (HPTLC) method for the simultaneous estimation of metformin hydrochloride (MET) and ursodeoxycholic acid (URSO) in pharmaceutical dosage form. The critical factors were identified using a Taguchi design, and after identification of critical factors, optimization was done using Box-Behnken design (BBD). BBD was used to optimize the compositional parameters and to evaluate the main effect, interaction effects, and quadratic effects of the mobile phase compositions, development distance, and saturation time on the retardation factor (RF) of both drugs. HPTLC separation was performed on aluminum plates pre-coated with silica gel 60 F254 as the stationary phase, using toluene–ethanol–acetone–formic acid (4.5:2:2.5:0.85, V/V) as the mobile phase at a wavelength of 234 nm and 700 nm for MET and URSO, respectively. A sharp and well-resolved peak was obtained for MET and URSO at RF values of 0.19 and 0.80 min, respectively. The calibration curve was in the range of 5000–40000 ng per spot and 1500–12000 ng per spot for MET and URSO, with r2 = 0.984 and r2 = 0.980, respectively. The method was validated for linearity, accuracy, precision, limit of detection, limit of quantification, and specificity. To provide a better visualization of the statistically significant factors derived from the statistical analysis, the perturbation plot and response surface plot for the effect of independent variables on the RF of MET and URSO were evaluated. Stability study was performed under different stress conditions such as acid and alkali hydrolysis, oxidation, and temperature. The developed method was able to resolve drugs and their degradation products formed under the afore-mentioned conditions.

  • [1]

    K.D. Tripathi , Essential medical pharmacology, 6th edn., Jaypee Brothers Medical Publishers (P) Ltd., New Delhi, 2008, p. 254255.

  • [2]

    A. Roda , A. Giocchini, A. Marietta, C. Cerre, M. Montagnani, A. Fini, J. Gastroenterol. 27 (1995) 327331.

  • [3]

    J. Maryadele , O. Neil, The Merck Index: an encyclopedia of chemicals, drugs and biological, 15th edn., Merck Research Laboratories, Whitehouse Station, NJ, 2013.

    • Search Google Scholar
    • Export Citation
  • [4]

    H.P. Chhetri , P. Thapa, A. V. Schepdael, Simple HPLC-UV method for the quantification of metformin in human plasma with one step protein precipitation, Saudi Pharm. J. 22 (2014) 483487.

    • Search Google Scholar
    • Export Citation
  • [5]

    B.S. Rao , S.S. Dubey, N.K. Rao, V.B. Kiran, Development and validation of reverse phase RP-HPLC method for the determination of metformin HCl in pharmaceutical dosage forms, Asian J. Chem. 24 (2012) 54605462.

    • Search Google Scholar
    • Export Citation
  • [6]

    Y. Harahap , K. Dianpratami, M. Wulandari, R. Rahmawati, Validation of metformin hydrochloride in human plasma by HPLC-photo diode array (PDA) for application of bioequivalence study, J. Life Sci. 6 (2012) 2027.

    • Search Google Scholar
    • Export Citation
  • [7]

    J. Mukherjee , T.K. Pal, Development and validation of RP-HPLC method to determine ursodeoxycholic acid in pharmaceutical dosage forms, Int. J. Pharm. Sci. Res. 2 (2011) 7173.

    • Search Google Scholar
    • Export Citation
  • [8]

    M. Kar , P.K. Choudhury, HPLC method for estimation of metformin hydrochloride in formulated microspheres and tablet dosage form, Indian J. Pharm. Sci. 71 (2009) 318320.

    • Search Google Scholar
    • Export Citation
  • [9]

    A. Peepliwal , K.G. Bothara, A validated RP-HPLC method for quantitative determination of related impurities of ursodeoxycholic acid (API) by refractive index detection, J. Pharm. Biomed. Anal. 54 (2011) 845849.

    • Search Google Scholar
    • Export Citation
  • [10]

    M. Reddy , G. Mubeen, M. Pal, HPTLC method for estimation of metformin hydrochloride, Biomed. Pharmacol. J. 1 (2016) 25.

  • [11]

    R. Miral , K. Pankaj, S. Ketan, Development and validation of stability indicating HPTLC method for pioglitazone hydrochloride and metformin hydrochloride, Res. J. Pharm. Tech. 9 (2016) 15551561.

    • Search Google Scholar
    • Export Citation
  • [12]

    P. Jain , D. Girase, A. Bedse, S. Surana, Stability indicating HPTLC densitometry method for determination of metformin hydrochloride in tablet formulation, J. Pharm. Biosci. 2 (2013) 5158.

    • Search Google Scholar
    • Export Citation
  • [13]

    S. Gurule , D. Goswami, A. Saha, Y. Modhave, A.K. Monif, Bioanalytical method development and validation using incurred samples: Quantitative estimation of metformin in human K3EDTA plasma by LC-MS/MS, Clin. Res. Regul. Aff. 29 (2012) 13.

    • Search Google Scholar
    • Export Citation
  • [14]

    D. Michela , C.M. Gauntb, T. Arnasonc, A. Elaneeda, Development and validation of fast and simple flow injection analysis-tandem mass spectrometry (FIA-MS/MS) for the determination of metformin in dog serum, J. Pharm. Biomed. Anal. 107 (2015) 229235.

    • Search Google Scholar
    • Export Citation
  • [15]

    K. Noor , G. Mubeen, Spectrophotometric method for analysis of metformin hydrochloride, Indian J. Pharm. Sci. 71 (2009) 100102.

  • [16]

    P. Mahadik , D. Dahia, T. Mani, P. Gaikwad, S. Gavali, Method development and validation of metformin in bulk and pharmaceutical dosage forms by using spectrophotometric method, Am. J. Pharm. Tech. Res. 2 (2012) 350355.

    • Search Google Scholar
    • Export Citation
  • [17]

    J.A. Wass , First steps in experimental design - The screening experiment, J. Valid. Technol. 16 (2010) 4653.

  • [18]

    V.P. Patel , H.D. Shihora, Experimental design and patent, 1st edn., Akshat Publication, Gujarat, 2011, 135.

  • [19]

    G.E.P. Box , N.R. Draper, Response surfaces, mixtures, and ridge analyses, 2nd edn., John Wiley & Sons, Hoboken, NJ, 2007, 129200.

  • [20]

    M. Bakshi , S. Singh, Development of validated stability-indicating assay methods – critical review, J. Pharm. Biomed. Anal. 28 (2002) 10111040.

    • Search Google Scholar
    • Export Citation
  • [21]

    ICH, Stability Testing for New Dosage Forms in International Conference on Harmonization, IFPMA, Geneva, 1996.

  • [22]

    ICH, Q2 (R1) Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonization, IFPMA, Geneva, 2005.

    • Search Google Scholar
    • Export Citation

For Submission Guideline click HERE

Manuscript Submission: JPC Manuscript Submission

Senior editors

Editor(s)-in-Chief: B. Spangenberg

Managing Editor: Kakuk Ágnes

Editorial Board

  • T.H. Dzido (Lublin, Poland)
  • Á. M. Móricz (Budapest, Hungary)
  • C.F. Poole (Detroit, MI, USA)
  • E. Reich (Muttenz, Switzerland)
  • B. Renger (Radolfzell, Germany)
  • I. Vovk (Ljubljana, Slovenia)

 

Advisory Board

  • E. BODOKI (Cluj-Napoca, Romania)
  • U. A. TH. BRINKMAN (Amsterdam, The Netherlands)
  • I. CHOMA (Lublin, Poland)
  • V. COMAN (Cluj-Napoca, Romania)
  • W. DAMMERTZ (Kressbronn, Germany)
  • K. FERENCZI-FODOR (Budapest, Hungary)
  • G. INDRAYANTO (Surabaya, Indonesia)
  • R. E. KAISER (Bad Dürkheim, Germany)
  • I. KLEBOVICH (Budapest, Hungary)
  • T. KOWALSKA (Katowice, Poland)
  • L. LEPRI (Florence, Italy)
  • E. MINCSOVICS (Budapest, Hungary)
  • D. NUROK (Indianapolis, IN, USA)
  • B. RENGER (Radolfzell, Germany)
  • J. K. RÓŻYŁO (Lublin, Poland)
  • J. SHERMA (Easton, PA, USA)
  • M. WAKSMUNDZKA-HAJNOS (Lublin, Poland)
  • D. WEDGE (Mississippi, USA)

A. Kakuk - Managing Editor, Akadémiai Kiadó
Address: P.O. Box 245. H-1519 Budapest, Hungary
Fax: +36 1 464 82 95
E-mail: jpc@akkrt.hu

Indexing and Abstracting Services:

  • Science Citation Index
  • Sci Search Research Alert
  • Chemistry Citation Index and Current Content/Physical
  • Chemical and Earth Sciences

 

Journal of Planar Chromatography - Modern TLC
Language English
Size A4
Year of
Foundation
1988
Volumes
per Year
1
Issues
per Year
6
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Springer Nature Switzerland AG
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
CH-6330 Cham, Switzerland Gewerbestrasse 11.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0933-4173 (Print)
ISSN 1789-0993 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 12 0 0
May 2021 4 0 0
Jun 2021 6 0 0
Jul 2021 5 0 0
Aug 2021 11 0 0
Sep 2021 12 0 0
Oct 2021 0 0 0